Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL34901 | 0.98 | KIF11 (0.96) | KIF11 | |
| Cysteamine SCHEMBL3970283 | 0.90 | KIF11 (0.81) | KIF11 | |
| SCHEMBL14945645 | 0.89 | KIF11 (1.00) | KIF11 | |
| SCHEMBL20101561 | 0.89 | KIF11 (1.00) | KIF11 | |
| SCHEMBL19371248 | 0.87 | KIF11 (0.77) | KIF11 | |
| Trifluoroacetic Acid SCHEMBL7734330 | 0.86 | KIF11 (0.73) | KIF11 | |
| SCHEMBL25400195 | 0.85 | KIF11 (0.74) | KIF11 | |
| SCHEMBL12417490 | 0.84 | KIF11 (1.00) | KIF11 | |
| SCHEMBL98804 | 0.84 | KIF11 (0.71) | KIF11 | |
| Lactic Acid SCHEMBL11871190 | 0.83 | KIF11 (0.69) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260007777-A1 | HEPTAMETHINE CYANINE NEAR-INFRARED FLUORESCENT DYE, PREPARATION METHOD THEREFOR AND USE THEREOF | NANJING NUOYUAN MEDICAL DEVICES CO LTD (CN) | 2026-01-08 | — | — | US | claimed |
| CN-119661841-A | Prodrug molecule based on zwitterionic polyamide-amine dendrimer, nano drug-loaded micelle, and preparation method and application thereof | 燕山大学 | 2025-03-21 | — | — | CN | claimed |
| CN-118185266-B | Degradable material added with bamboo fibers | 福建德绿新材料科技有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-118048050-B | Heptamethine cyanine near-infrared fluorescent dye and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-118185266-A | Degradable material added with bamboo fibers | 福建德绿新材料科技有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118048050-A | Heptamethine cyanine near-infrared fluorescent dye and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-116178731-A | Additive for enhancing immunity of livestock and poultry, preparation method and application thereof | 福建傲农生物科技集团股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| US-20220133753-A1 | COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES CHARACTERIZED BY INSUFFICIENT PANTOTHENATE KINASE ACTIVITY | VECTIVBIO COMET AG, F/K/A COMET THERAPEUTICS, INC. (CH) | 2022-05-05 | — | — | US | claimed |
| CN-107365351-B | Marine natural product lactam type Largazole analogue, preparation method and application thereof | 复旦大学 | 2022-02-01 | — | — | CN | claimed |
| CN-107365323-B | Amide type analogue of marine natural product Largazole, preparation method and application thereof | 复旦大学 | 2020-06-09 | — | — | CN | claimed |
| US-20190255079-A1 | COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES CHARACTERIZED BY INSUFFICIENT PANTOTHENATE KINASE ACTIVITY | COMET THERAPEUTICS B.V. (NL) | 2019-08-22 | — | — | US | claimed |
| EP-3471828-A1 | COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES CHARACTERIZED BY INSUFFICIENT PANTOTHENATE KINASE ACTIVITY | Acies Bio d.o.o. (SI) | 2019-04-24 | — | — | EP | claimed |
| US-20180059072-A1 | HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR ANALYSIS OF MN DIAGNOSTIC AND THERAPEUTIC LIGAND AND PRECURSOR | INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, Executive Yuan, R.O.C. (TW) | 2018-03-01 | — | — | US | claimed |
| WO-2017218963-A1 | COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES CHARACTERIZED BY INSUFFICIENT PANTOTHENATE KINASE ACTIVITY | ACIES BIO D.O.O. (SI) | 2017-12-21 | — | — | WO | claimed |
| US-9227931-B1 | Bifunctional compound and method for manufacturing the same | Atomic Energy Council—Institute of Nuclear Energy Research (TW) | 2016-01-05 | — | — | US | claimed |
| US-9150602-B2 | Precursor used for labeling hepatorcyte receptor and containing trisaccharide and diamide demercaptide ligand, method for preparing the same, radiotracer and pharmaceutical composition of the same | ATOMIC ENERGY COUNCIL, INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2015-10-06 | — | — | US | claimed |
| US-20140031533-A1 | PRECURSOR USED FOR LABELING HEPATORCYTE RECEPTOR AND CONTAINING TRISACCHARIDE AND DIAMIDE DEMERCAPTIDE LIGAND, METHOD FOR PREPARING THE SAME, RADIOTRACER AND PHARMACEUTICAL COMPOSITION OF THE SAME | ATOMIC ENERGY COUNCIL, INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2014-01-30 | — | — | US | claimed |
| US-8329879-B2 | H3LMN compound used as radioactive agent for treatment of liver cancer and manufacturing method thereof | ATOMIC ENERGY COUNCIL-INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2012-12-11 | — | — | US | claimed |
| US-20110065904-A1 | H3LMN COMPOUND USED AS RADIOACTIVE AGENT FOR TREATMENT OF LIVER CANCER AND MANUFACTURING METHOD THEREOF | ATOMIC ENERGY COUNCIL-INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2011-03-17 | — | — | US | claimed |
| US-4002671-A | REDUCE SEBUM SECRETION ON SCALP OR SKIN | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-01-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065904-A1 | H3LMN COMPOUND USED AS RADIOACTIVE AGENT FOR TREATMENT OF LIVER CANCER AND MANUFACTURING METHOD THEREOF | L3MBTL3, LIPC, L3MBTL4 | KIF11 1228/4885 |
| US-20260007777-A1 | HEPTAMETHINE CYANINE NEAR-INFRARED FLUORESCENT DYE, PREPARATION METHOD THEREFOR AND USE THEREOF | HCCS, PYGL, GOT1 | KIF11 235/4885 |
| US-20190255079-A1 | COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES CHARACTERIZED BY INSUFFICIENT PANTOTHENATE KINASE ACTIVITY | PANK1, PANK3, PHKG1 | KIF11 4141/4885 |
| US-20140031533-A1 | PRECURSOR USED FOR LABELING HEPATORCYTE RECEPTOR AND CONTAINING TRISACCHARIDE AND DIAMIDE DEMERCAPTIDE LIGAND, METHOD FOR PREPARING THE SAME, RADIOTRACER AND PHARMACEUTICAL COMPOSITION OF THE SAME | ASGR1, M6PR, DDOST | KIF11 3338/4885 |
| US-20220133753-A1 | COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES CHARACTERIZED BY INSUFFICIENT PANTOTHENATE KINASE ACTIVITY | PANK1, PANK3, PHKG1 | KIF11 4141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.